Clinical Trials
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.